Freestone Grove Partners LP Purchases New Shares in Acadia Healthcare Company, Inc. $ACHC

Freestone Grove Partners LP purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 643,486 shares of the company’s stock, valued at approximately $19,002,000. Freestone Grove Partners LP owned about 0.69% of Acadia Healthcare as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of ACHC. BlackRock Inc. bought a new stake in Acadia Healthcare during the 2nd quarter worth about $441,685,000. Goldman Sachs Group Inc. raised its position in shares of Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the period. Jefferies Financial Group Inc. bought a new position in Acadia Healthcare in the fourth quarter valued at approximately $47,960,000. Wellington Management Group LLP lifted its position in Acadia Healthcare by 24.9% in the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after acquiring an additional 2,350,760 shares in the last quarter. Finally, Vaughan Nelson Investment Management L.P. bought a new stake in shares of Acadia Healthcare in the first quarter valued at about $43,017,000.

Acadia Healthcare Stock Down 1.2%

Acadia Healthcare stock opened at $30.22 on Friday. The company’s 50-day moving average price is $30.39 and its two-hundred day moving average price is $26.04. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The stock has a market cap of $2.81 billion, a P/E ratio of -2.43, a P/E/G ratio of 9.85 and a beta of 0.64. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm’s revenue for the quarter was down .4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, analysts expect that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

Wall Street Analyst Weigh In

ACHC has been the topic of a number of research reports. Barclays boosted their price objective on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. Raymond James Financial raised Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective for the company in a research report on Monday, May 4th. Guggenheim boosted their target price on Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. KeyCorp increased their price target on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Finally, TD Cowen raised their price target on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Hold” and an average price target of $29.85.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.